Systemic inflammation, nutritional status and survival in patients with cancer.
about
Cancer cachexia--pathophysiology and managementCancer-Associated Immune Resistance and Evasion of Immune Surveillance in Colorectal CancerElevated Preoperative Neutrophil-Lymphocyte Ratio Is Associated with Poor Prognosis in Hepatocellular Carcinoma Patients Treated with Liver Transplantation: A Meta-AnalysisHypoalbuminemia in colorectal cancer prognosis: Nutritional marker or inflammatory surrogate?Pancreatic cancer surgery and nutrition management: a review of the current literaturePrognostic significance of neutrophil to lymphocyte ratio in pancreatic cancer: a meta-analysisCancer induces cardiomyocyte remodeling and hypoinnervation in the left ventricle of the mouse heartPrognostic Importance of Controlling Nutritional Status in Patients Undergoing Curative Thoracoscopic Esophagectomy for Esophageal Cancer.Association of nutritional status and serum albumin levels with development of toxicity in patients with advanced non-small cell lung cancer treated with paclitaxel-cisplatin chemotherapy: a prospective study.Prognostic factors for recurrence-free and overall survival after adrenalectomy for metastatic carcinoma: a retrospective cohort pilot study.Plasma MIC-1 correlates with systemic inflammation but is not an independent determinant of nutritional status or survival in oesophago-gastric cancer.Development and validation of nomograms for predicting survival in patients with non-metastatic colorectal cancer.A high angiopoietin-2/angiopoietin-1 ratio is associated with a high risk of septic shock in patients with febrile neutropeniaSocial network ties and inflammation in U.S. adults with cancer.Prognostic value of PLR in various cancers: a meta-analysis.C-reactive protein, symptoms and activity of daily living in patients with advanced cancer receiving palliative care.Modified glasgow prognostic score in patients with small-cell lung cancerGlasgow prognostic score after concurrent chemoradiotherapy is a prognostic factor in advanced head and neck cancer.Prognostic significance of preoperative fibrinogen in patients with colon cancerOmega-3 polyunsaturated fatty acids augment the muscle protein anabolic response to hyperinsulinaemia-hyperaminoacidaemia in healthy young and middle-aged men and womenThe bodies fight against cancer: is human leucocyte antigen (HLA) class 1 the key?Systemic inflammation, nutritional status and tumor immune microenvironment determine outcome of resected non-small cell lung cancerThe modified glasgow prognostic score is an independent prognostic factor in patients with inoperable thoracic esophageal squamous cell carcinoma undergoing chemoradiotherapyA clinical risk score to predict 3-, 5- and 10-year survival in patients undergoing surgery for Dukes B colorectal cancer.The relationship between the presence and site of cancer, an inflammation-based prognostic score and biochemical parameters. Initial results of the Glasgow Inflammation Outcome StudyPrognostic significance of systemic inflammation-based lymphocyte- monocyte ratio in patients with lung cancer: based on a large cohort study.Prognostic significance of complications after laparoscopic colectomy for colon cancer.Elevated preoperative peripheral blood monocyte count predicts poor prognosis for hepatocellular carcinoma after curative resection.Prognostic value of preoperative inflammatory markers in Chinese patients with breast cancerThe relationships between body composition and the systemic inflammatory response in patients with primary operable colorectal cancer.The modified Glasgow Prognostic Scores as a predictor in diffuse large B cell lymphoma treated with R-CHOP regimen.Cancer cachexia: traditional therapies and novel molecular mechanism-based approaches to treatment.The Glasgow Prognostic Score predicts poor survival in cisplatin-based treated patients with metastatic nasopharyngeal carcinoma.An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study.Cancer cachexia: mechanisms and clinical implications.Systemic zinc redistribution and dyshomeostasis in cancer cachexia.Association between levels of C-reactive protein and leukocytes and cancer: three repeated measurements in the Swedish AMORIS studyNeutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer.Elevated platelet count as predictor of recurrence in rectal cancer patients undergoing preoperative chemoradiotherapy followed by surgery.The pretreatment albumin to globulin ratio has predictive value for long-term mortality in nasopharyngeal carcinoma
P2860
Q24605567-664DDB91-B36F-4245-B5BA-752C8723CE25Q26752491-32991A27-3003-4FAA-803A-745DE01B0D49Q26769591-6D06A1E2-4DD3-4F5E-A572-9D408038AFC0Q26771133-2EF611FF-FC25-4A0C-84D8-BC9660E5419FQ26864279-62585E3E-22A8-41BF-B356-B912E8807BACQ28083684-C961E967-952A-4DE8-917C-9731C5594265Q30475241-D1A81F8E-24DF-4B59-9133-F38E8BF4BBE7Q30488933-AF04BACE-690D-485A-83E8-BAA1C549BA60Q33532808-014F89E6-E6AF-490D-948E-6CECE5F1A230Q33673109-59D0E164-9B3B-42F0-9210-4C6DCDDBFF1EQ33723662-3A824E2D-407E-4A98-8D68-31CAABB6DAD2Q33728174-7CEFAD0C-E771-415E-8378-F05B5A5DA085Q33752686-63569BE2-28D9-4877-A587-35A3442C8676Q33781020-9A00AF65-9B8A-4030-AA31-1DD0A0AD6782Q33812584-B3BA1B2A-5844-4C34-B5BD-89D10C7611F5Q33813575-CED507C1-828F-45AE-AEB8-2A2460D80B60Q33857754-283783DB-E927-4E0A-A3D4-FB2E91F0F9F2Q33871869-4113D0BC-03E2-42C0-BCCD-8175F59C19CFQ33887040-994B174A-4720-46AF-9914-314C09271FABQ34179131-F0658B26-F665-417E-A6AB-D6E4770E01F1Q34199253-4150429A-66F0-43CE-9E3E-38325DE42ED3Q34215504-0ABE97BE-9C42-4926-A4F3-B1B4B79DE60FQ34241072-B7488082-DBFE-42C5-8B93-D42A2662925EQ34250179-5C6CD47C-3092-42DB-9361-D623E12CAC8EQ34253740-3C01837B-7155-4054-80BF-9C6761216B7DQ34281919-FD2C02FA-88E9-4B4A-920C-A2E34460EAB1Q34315329-21C0D6E7-A289-48B0-B607-93955EA4A2ADQ34316969-66237161-DEB6-47D9-BE82-A66A6FF87F2FQ34337667-0A8608D6-BD60-46AC-B3F2-A50A9C19B51EQ34369105-DC9FB61C-9873-49FB-800B-8D5728105C8FQ34384335-79135B85-990B-4E9E-9DA5-81E72C316BB1Q34470745-1C190B22-090B-4134-9FDE-0F97555EE892Q34506005-7CEEF1DB-7C1D-4AF0-9FC3-1D6E11FDE218Q34627925-25330805-CC89-4336-8766-10F6CFB0A352Q34631019-D3BCB361-5D6A-42EB-85C3-16B7ED5512EDQ34697225-E7F9752F-AC99-4301-8060-BFAE8C589CB0Q34806349-7F605AAC-9900-4EEC-BCCF-6D7C6CFE4639Q34806672-5B10B8BF-262D-4417-A818-FEC255057C04Q35110652-29F6F9FF-2D66-460C-8D77-1F007816DAA8Q35144019-BA49624C-8A6F-40EE-85C7-0C5D21004E79
P2860
Systemic inflammation, nutritional status and survival in patients with cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Systemic inflammation, nutritional status and survival in patients with cancer.
@en
Systemic inflammation, nutritional status and survival in patients with cancer.
@nl
type
label
Systemic inflammation, nutritional status and survival in patients with cancer.
@en
Systemic inflammation, nutritional status and survival in patients with cancer.
@nl
prefLabel
Systemic inflammation, nutritional status and survival in patients with cancer.
@en
Systemic inflammation, nutritional status and survival in patients with cancer.
@nl
P1476
Systemic inflammation, nutritional status and survival in patients with cancer
@en
P2093
Donald C McMillan
P304
P356
10.1097/MCO.0B013E32832A7902
P577
2009-05-01T00:00:00Z